Author:
Eckard Matthew L.,Kinsey Steven G.
Funder
National Institute on Drug Abuse
National Institutes of Health
Subject
Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry
Reference44 articles.
1. Quantifying the clinical significance of cannabis withdrawal;Allsop;PLoS One,2012
2. Beardsley, P. M., & Martin, B. R. (2000). Effects of the Cannabinoid CB 1 Receptor Antagonist, SR141716A, After D 9 -Tetrahydrocannabinol Withdrawal q. 47–53.
3. Dependence on tetrahydrocannabinol in Rhesus monkeys;Beardsley;J. Pharmacol. Exp. Ther.,1986
4. The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats;Bortolato;Psychopharmacology,2005
5. The cannabis withdrawal syndrome;Budney;Curr. Opin. Psychiatry,2006